Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
03/2011
03/08/2011CA2487532C Pyrrolidine derivatives as oxytocin antagonists
03/08/2011CA2446756C Thiazole compounds useful as inhibitors of protein kinase
03/02/2011CN1769251B Oligonaphthalene derivatives, and light-emitting element and light-emitting device using oligonaphthalene derivatives
02/2011
02/23/2011EP1409461B1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides
02/23/2011CN101979394A A method to inhibit ethylene responses in plants
02/17/2011US20110039802 Npy y5 antagonist
02/16/2011EP1379498B1 Sulphones which modulate the action of gamma secretase
02/09/2011CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis
02/08/2011CA2446924C 2-iminopyrrolidine derivatives
02/02/2011EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
02/01/2011US7879995 organic electroluminescent device has, between a pair of electrodes, at least one organic layer including a light-emitting layer, in which the organic layer contains a specific tetraphenylene compound
02/01/2011CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas
01/2011
01/26/2011EP2277879A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
01/25/2011CA2494323C Amino benzothiazole compounds with nos inhibitory activity
01/25/2011CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives
01/20/2011US20110015360 Dithiocarbamic esters
01/19/2011EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds
01/18/2011CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
01/12/2011EP2272813A2 Copper-catalyzed formation of carbon-oxygen bonds
01/12/2011CN101945872A (1-azinone) -substituted pyridoindoles as mch antagonists
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011CA2385592C Benzamides and related inhibitors of factor xa
01/04/2011CA2458533C Imidazole derivates as anti-inflammatory agents
01/04/2011CA2454703C Novel thiophene carboxamide derivatives
12/2010
12/29/2010EP2266986A1 Cytotoxins, Prodrugs, Linkers and Stabilizers useful therefor
12/28/2010US7858802 Method of preparing ionic liquids
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/21/2010US7855297 Amide derivatives and medicinal use thereof
12/21/2010CA2401778C Benzamides and related inhibitors of factor xa
12/14/2010CA2391274C Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/07/2010US7847101 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors
12/01/2010CN101899039A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
12/01/2010CN101898982A Npy y5 antagonists
11/2010
11/30/2010CA2144474C Substituted n-ethylglycine derivatives for preparing pna and pna/dna hybrids
11/25/2010US20100298284 Benzamides and related inhibitors of factor xa
11/24/2010EP2253620A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP1233936B2 Process for preparing ambient temperature ionic liquids
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010CA2404755C Imidazole carbenes
11/18/2010US20100292500 Npy y5 antagonist
11/16/2010CA2404680C Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds
11/11/2010US20100286197 Carboxamide Derivatives As Therapeutic Agents
11/11/2010US20100285963 Substituted fluoroalkoxyphenylsulfonylureas
11/04/2010US20100280042 Quinazoline derivatives for the treatment of tumours
11/03/2010EP1496838B1 Substituted amides
11/02/2010US7825193 Dithiocarbamic esters
11/02/2010US7825124 Indolylmaleimide derivatives
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof
10/20/2010EP2240481A1 (1-azinone) -substituted pyridoindoles as mch antagonists
10/20/2010EP1283832B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010CA2400479C Platelet adp receptor inhibitors
09/2010
09/29/2010EP1421074B1 Novel compounds
09/29/2010EP1399402B1 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
09/22/2010EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
09/22/2010EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP2027132B1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/14/2010CA2422805C Retinoids for the treatment of emphysema
09/08/2010EP1841741B1 Piperidine derivatives as prodrugs of potassium channel inhibitors
09/08/2010CN1798746B Reverse-turn mimetics and method relating thereto
09/07/2010US7790902 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
09/07/2010US7790719 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
08/2010
08/31/2010US7786161 prostaglandin receptor antagonists such as 2-(2-((4-methyl-2-(naphthalen-1-yl)pentanoyl)amino)-4-(pyrazol-1-ylmethyl) benzyl)benzoic acid, used for the prevention and/or treatment of diseases induced pain, skin disorders, allergies, urogenital disorders, Alzheimer's disease, cancer and dysmenorrhea
08/31/2010US7786156 reacting [2-(5-Hydrazinomethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine with a 1,2,4-triazolyl forming reagent such as 1,3,5-triazine, formamidine, formamidinium salts or formamide, to obtain (3-[2-(dimethylamino)ethyl]-5-(1,2,4-triazol-1-ylmethyl)indole)
08/31/2010US7786131 Anticancer agents; restenosis; atherosclerosis; skin disorders
08/31/2010US7786123 Indolylmaleimide derivatives
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010CA2438991C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/11/2010EP1537099B1 Pyrrole based inhibitors of glycogen synthase kinase 3
08/11/2010CN101798298A Imidazole derivatives
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772224 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches
08/05/2010US20100197736 Cetp activity inhibitors
07/2010
07/27/2010CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor
07/20/2010CA2290136C New erythromycin derivatives, the process for preparing them and their use as a drug product
07/13/2010US7754053 Distillation of ionic liquids
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/06/2010US7750151 Inhibitors of Akt activity
06/2010
06/30/2010EP1495035B1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
06/30/2010EP1278735B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
06/29/2010US7745472 Dimethylsulfamic Acid 2-bromo-4-{[(4-cyano-phenyl)-[1,2,4]triazol-4-ylamino]methyl}phenyl Ester, used as effective sulfatase and/or aromatase inhibitors, and as modulators of cell cycling and modulators of apoptosis; therapy of breast, prostate, ovarian or endometrial cancer
06/29/2010CA2442885C Sulphones which modulate the action of gamma secretase
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 163